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Luminal arginine vasopressin stimulates Na-H exchange and H+
ATPase in cortical distal tubule via Vi receptor. Bicarbonate reabsorption
was evaluated by stationary microperfusion of in vivo early distal (ED) and
late distal (LD) segments of rat kidney. Intratubular pH was recorded by
double-barreled H ion-exchange resin/reference (1 M KC1) microelec-
trodes for the determination of HCO3 reabsorption. In the presence of
luminal arginine vasopressin (AVP, 10 M), a significant increase in
HCO3 reabsorption was observed both in ED (from 0.931 0.061 to
2.12 0.171 nmol cm2 . s] and LD segments [from 0.542 0.086 to
1.67 0.111 nmol cm2 s. The addition of the Vi-receptor
antagonist [(d (CH2)5, Tyr (Et)2) arginine vasopressin] (10 M) to luminal
perfusion blocked luminal AVP mediated stimulation in ED and LD
segments. 5-(N, N-hexamethylene) amiloride (10—a M) added to luminal
perfusion inhibited luminal AVP-mediated stimulation in ED (by 63.7%)
and LD (by 34.1%) segments. The addition of Bafilomycin A1 (2 X iO
M) to the luminal perfusion did not affect luminal AVP-mediated stimu-
lation in ED segments, but reduced it (by 31.7%) in LD segments. Our
results indicate that luminal AVP acts to stimulate the Na-H exchange
in ED and LD segments via activation of Vi receptors, as well as the
vacuolar H-ATPase in LD segments.
The major action of arginine vasopressin (AVP) in the kidney
is to increase water permeability in the cortical (CCD) and inner
medullaty collecting ducts (IMCD) [1]. However, AVP has also
been shown to be involved in tubular fluid acidification. In the rat
kidney, AVP inhibits bicarbonate reabsorption in the thick as-
cending limb [2, 3] and stimulates proton secretion (or bicarbon-
ate reabsorption) in the distal tubule [2, 4] and CCD [2, 51. The
nature of the mechanism underlying AVP action on bicarbonate
reabsorption is, however, not yet clearly defined. In mesangial
cells AVP stimulates the Na-H exchanger [6, 7] as well as the
Natdependent or independent CIIHCO3 - exchangers [6]. In
A6 cells (an amphibian distal nephron cell line), however, the
addition of AVP either at low (subnanomolar) or at high (micro-
molar) concentrations inhibits the basolatcral Na-H-exchange
activity [8]. Studies in isolated perfused mouse medullary thick
ascending limbs showed that AVP stimulates the hasolateral cells
while simultaneously inhibiting the apical Na1 -H1 antiporter [91.
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Thus, it is possible that the difference in AVP response of
Na-H exchangers may vary with the cell type being studied.
Since the concentration of AVP in the luminal fluid may exceed
1,000-fold that of plasma [10, 11], and considering the possible
existence of functional luminal vasopressin receptors [12, 13], the
present study was designed to determine whether luminal AVP
(10— M) regulates acid-base transport in the rat cortical distal
tubule. For this purpose, we evaluated the kinetics of HC03
reabsorption by the stationary microperfusion technique in in vivo
early distal (ED) and late distal (LD) segments. In order to detect
which specific process AVP stimulates distal bicarbonate reab-
sorption, we also examined the effects of the Vi and V2 receptor
antagonists [(d (CH2)5, Tyr (Et)2) arginine vasopressin and
(Adamantaneacetyl1,O-Et-D-Tyr2,Val4, Aminobutyryl6, Arg8'9)
vasopressin, respectively], of the specific blocker of Na*H±
exchanger [5-(N, N-hexamethylene) amiloride, HMA] and of the
specific inhibitor of vacuolar H-ATPase [bafilomycin A1] on
luminal AVP stimulation in ED and LD segments.
METHODS
Male Wistar rats weighing 180 to 300 g were anesthetized with
mactin (Byk-Gulden, Konstanz, Germany), 100 mg/kg ip. Wistar
rats were obtained from Instituto de Ciências Biomédicas. They
received a rat pellet diet and water ad libitum until the time of the
experiment. The rats were prepared for in vivo micropuneture as
described previously [14]. In brief, the left jugular vein and left
carotid artery were cannulated for infusions and blood with-
drawal, respectively. A tracheostomy was performed. The kidney
was isolated by a lumbar approach and immobilized in situ by
Ringer-Agar in a Lucite cup. During the experiment, the rats
received venous saline containing 3% mannitol at 0.05 mI/mm.
We studied the kinetics of HCOI reabsorption in ED (distal
convoluted tubule) and LD (connecting tubule and initial collect-
ing duct) segments. The experiments were done during luminal
perfusion with AVP and with AVP plus specific inhibitors. In each
tubule, only one perfusion solution was used.
HC03 reabsorption was calculated from continuous measure-
ment of luminal p1-I by means of microelectrodes in a fluid column
isolated by castor oil in the tubule lumen that followed the
intratuhular p1-I changes toward the steady-state level [14, 15].
Briefly, the microperfusion procedure involved impalement of a
proximal loop with a double-barreled micropipette made from
theta glass tubing (R & D Optical Systems, Spencerville, MD,
USA), One barrel was filled with Sudan black-colored castor oil,
and the other was filled with the luminal perfusion solution
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colored with 0.05% FD & C green. Initially, the luminal perfusion
was used to detect ED or LD loops. A double-barreled micro-
eletrode was then inserted into the ED or LD loop. Afterward,
luminal perfusion was performed at a rate sufficient to elevate
luminal distal tubule loop pH to near that of the original perfusion
solution (pH 8). Then a column of oil was injected into the
proximal tubule lumen, blocking the flow of fluid. Intratubular pH
was measured as the voltage difference between the two barrels of
the microeletrode made from Hilgenberg (Malsfeld, Germany)
double-barreled asymmetric glass capillaries. The larger barrel
contained a H f-sensitive ion-exchange resin (Fluka, Buchs, Swit-
zerland), and the smaller one contained 1 M KCI colored by FD &
C green (reference barrel). Transepithelial electrical potential
difference (V1) was defined as the difference between the refer-
ence barrel and ground. This parameter was an additional crite-
rion for the recognition of ED or LD segments [16]. Intratubular
pH was measured concomitantly in the same tubule with Vt.
Voltages were read by a World Precision Instruments (New
Haven, CT, USA) model FD223 differential electrometer, the
output of which was digitized in I second intervals by means of an
analog-to-digital conversion board (Data Translation model DT
2801, Marlborough, MS, USA) mounted on a Dell 333 D micro-
computer.
The luminal pH fell from its initial value of 8 toward the
stationary level. Along this curve, intratubular concentrations of
HCO3 were calculated from intratubular pH values and from the
systemic partial pressure of carbon dioxide (PCO2) by use of the
Henderson-Hasselbalch equation at I second intervals, since we
have previously demonstrated that renal cortical PCO2 is similar
to that of arterial blood [17]. The rate of tubular acidification was
expressed as the half-time of the reduction of the injected HC03
levels to their stationary level (t1/2). Net HC03 reabsorption
(JHCO3) was calculated from the equation
JHCO1 = k([HC03] — [HCO3 ]) r/2
where k is the rate constant of the reduction of luminal bicarbon-
ate [k = ln2/(t112)], r is the tubule radius, and [HC03]1 and[HCO3] are the concentrations of the injected HC03 and
HC03 at the stationary level, respectively.
The pH microeletrodes were calibrated before and after every
impalement on the kidney's surface by superfusion with 20 mivi
phosphate Ringer buffer solutions containing 130 mtvi NaCI at
37°C. Their pH values were adjusted to 6.5, 7.0, and 7.5 with 0.1
N NaOH or HCI. The mean slope of 49 microelectrodes under our
experimental conditions was 60.1 2.28 mV per pH unit in the
range of 6.5 to 7.0 and 57.7 2.39 mV in the range of 7.0 to 7.5.
No significant interference of the presence of cations or anions
was observed [15].
The luminal control perfusion solution contained (in mM): 100
NaCl, 25 NaHCO3, 5 KCI, 1 CaCl2 and 1.2 MgSO4. The osmola-
lity was adjusted to 300 mOsm/kg H20 with raffinose.
AVP (mol wt 1.084; Sigma Chemical Company, St. Louis, MO,
USA) was added to luminal solution (10—p M). VI-receptor
specific antagonist (Anti-VI, [d (CH2)5, Tyr (Et)2] arginine vaso-
pressin) as well as V2-receptor specific antagonist (Anti-V2,
[AdamantaneacetyP, O-Et-D-Tyr2, Val4, Aminobutyryl6, Arg8'9]
vasopressin) were obtained from Sigma Chemical Company and
added to the luminal perfusion solution (10 NI and 10' M,
respectively). 5-(N,N-hexamethylene) amiloride (HMA; Merck,
Sharp, & Dohme, Rahway, NJ, USA), as well as bafilomycin A1
Table 1. Transcpithelial potential difference in early and late distal
tubule during luminal perfusion with AVP (10° M), Anti-Vi (10 M),
Anti-V2 (106 M), HMA (10 M) and Bafilomycin Al (2 >< iO NI)
Early distal Late distal
Control —17.5 0.75
(20/6)
—45.4 2.46
(17/6)
AVP —15.0 0.65
(19/9)
—46.7 1.20
(32/11)
Anti-Vi —14.5 0.38
(20/5)
—41.3 1.46
(24/6)
Anti-V2 —18.5 1.19
(27/8)
—44.6 2.62
(21/6)
AVP + Anti-VI —15.2 0.82
(19/5)
—38.9 1.58
(17/6)
AVP + Anti-V2 —20.7 1.07
(27/6)
—34.9 0.39
(19/5)
AVP + HMA —16.3 0.94
(22/7)
—39.9 1.18
(17/6)
AVP + BAF —12.9 0.99
(18/5)
—48.0 1.39
(22/7)
Values are means s; (N of measurements/N of tubuks). No
statistical differences were observed between the different experimental
groups and the respective control.
(obtained from Prof. K. Altendorf, University of Osnabruck,
OsnabrUck, Germany), were dissolved in dimethyl sulfoxide [15]
and added to luminal perfusion solution (HMA = 1O s and
bafilomycin A1 = 2 x iO M).
The pH and PCO2 in samples of blood collected from the
carotid artery were measured every 30 minutes with a Radiometer
Copenhagen ABL 5 blood gas system. In the groups of animals
with luminal perfusion with the hormone, we also measured
urinary flow and Na excretion. Na in urine collected from
urinary bladder was measured by flame photometry.
Statistics
Data are means SE. Differences between experimental groups
were evaluated by analysis of variance (one-way) with contrasts by
the Bonferroni technique, using N as the number of animals
(mean of several measurements) when urine or blood collection
was performed or the number of perfused tubules (mean of
several perfusions).
RESULTS
To detect whether the dose of AVP used during luminal
microperfusion would cause an effect on renal function and to
follow acid-base conditions, we measured urine flow (V), Na'
excretion and systemic acid-base parameters during the microper-
fusion experiments. During luminal perfusion with the hormone,
these data were similar to the control values [V, 0.149 0.014 ml
min kg'; urinary sodium flow, 8.81 0.978 j.tEq min'
kg'; pH, 7.40 0.14; PCO2, 39.2 0.65 mm Hg and HCO3,
24.8 1.1 mM, N = 12].
Table I gives mean data of V, in ED and LD segments during
tubular perfusions in all experimental conditions. No statistical
differences were observed between the different experimental
groups and the respective control.
Mean intratubular steady-state pH levels are given in Table 2.
In both ED or LD segments, values found during luminal
microperfusions in all experimental groups were not significantly
different from the control value.
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Table 2. Intratuhular steady-state pH in early and late distal tubule
during luminal perfusion with AVP (10 M), Anti-Vl (1O si),
Anti-V2 (106 M), HMA (10 M) and Bafilomycin (2 X iO M)
________ ________
Early distal Late distal
Control 6.77 0.06 6.53 0.27
(20/6) (17/6)
AVP 6.88 0.12 6.58 0.07
(19/9) (32/11)
Anti-Vi 6.56 0.07 6.57 0.06
(20/5) (24/6)
Anti-V2 6.46 0.08 6.74 0.11
(27/8) (21/6)
AVP + Anti-Vi 6.45 0.19 6.66 0.14
(19/5) (17/6)
AVP + Anti-V2 6.59 0.18 6.79 0.18
(27/6) (19/5)
AVP + HMA 6.68 0.08 6.46 0.14
(22/7) (17/6)
AVP + BAF 6.70 0.07 6.50 0.05
— ________ __________
(18/5) (22/7)
—
Values are means SE; (N of measurements/N of tubules). No
statistical differences were observed between the different experimental
groups and the respective control.
Fig. 1. Effect of luminal arginine vaSopressin io— M on HC03 reab-
sorption in early and late distal tubule. Values are means SE; N,
number of microperfusions/number of tubules; (fl) t112, half-time of
reduction of concentration of the injected HC03; () JHCO3, net
HC01 reabsorption. *P < 0.01 compared with control. Abbreviations
are: C, control; AVP, arginine vasopressin.
Effect of AVP 10 M
Figure 1 demonstrates that AVP added to the luminal solution
significantly stimulates HCO3 reabsorption in ED or LD seg-
ments. In ED segments, the half-time of acidification (t112)
decreased from 10.2 0.531 seconds (N of perfusions/N of
tubules = 20/6) during control luminal perfusion to 4.81 0.341
seconds (19/9) (P < 0.01) when AVP was added to lumen, and
consequently JHCO3 increased from 0.931 0.061 to 2.12
0.171 nmol cm 2 s 1 (P < 0.01). In LD segments the t112
decreased from 10.6 0.432 seconds (17/6) during control
luminal perfusion to 4.33 0.201 seconds (32/11) (1' < 0.01) when
AVP was used, and JI-1C03 increased from 0.542 0.086 to
1.67 0.111 nmol cm2 (P < 0.01).
To determine and investigate which specific receptor AVP
j:
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Fig. 2. Effect of luminal Anti-Vi 10 M or Anti-V2 iO M on HC03
reabsorption in early and late distal tubule. Experiments were done in
early A) and late (B) distal tubules. Values are means SE; N, number
of microperfusions/number of tubules. Symbols are as in Figure 1.
stimulates distal bicarbonate reabsorption at the apical mem-
brane, in the following experiments luminal perfusion with VI and
V2-receptor specific antagonists were used.
Effect of Anti-Vi 10 M and Anti-V2 106 M
Figure 2 shows the effects of luminal Vi or V2-reeeptor
antagonists on tubular acidification in both ED (Fig. 2A) and LD
(Fig. 2B) segments. In ED tubules, when Anti-Vi was used the t112
was 12.1 0.551 seconds (20/5) and JHCO3 was 0.82 0.037
nmol cm2 s , and when Anti-V2 was administered the t112 was
9.23 0.291 seconds (27/8) and the JHCO3 was 0.94 0.112
nmol cm2 s. In LD tubules, with Anti-Vi luminal solution
the t1,2 was 12.6 0.672 seconds (24/6) and JHCOI was 0.69 I
0,038 nmol cm2 s , and when Anti-V2 was used the t1,2 was
10.3 0.521 seconds (21/6) and the JHCO3 was 0.53 0.073
nmol cm 2,s. These data demonstrate that VI or V2-receptor
antagonists have no intrinsic effects on luminal acidification in
both ED and LD segments.
Figure 3 shows that luminal AVP stimulates HC03 reabsorp-
tion both in ED (Fig. 3A) and LD (Fig. 3B) segments via acti-
vation of Vi receptors. In the group where AVP plus Anti-Vi was
administered, the parameters of acidification were not signifi-
cantly different from the control group: in the ED segment the t1,2
was 11.5 0.772 seconds (19/5) and JHCO was 0.891 0.075
nmol' cm2 and in the LD segment the ti!22 was 10.5 0.611
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Fig. 3. Effect of luminal arginine vasopressin i0 M plus Anti-Vi i0 M
or Anti-V2 10—6 M on HCO, reabsorption. Experiments were done in
early 1A) and late (B) distal tubules. Values are means SE; N, number
of microperfusions/number of tubules. Abbreviations and symbols are as
in Figure 1. P < 0.01 compared with control. #P < 0.01 compared with
AVP.
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Fig. 4. Effect of luminal arginine vasopressin iO M plus 5-(N, N-
hexamethylene) amiloride (HMA, iO M) or plus Bafilomycin A1 (2 x
io— M) on HC03 reabsorption. Experiments were done in early (A) and
late (B) distal tubules. Values are means SE; N, number of microper-
fusions/number of tubules. Abbreviations are: C, control; AVP, arginine
vasopressin; HMA, 5-(N,N-hexamethylene) amiloride; BAF, Bafilomycin
A1. Symbols are: (LII) t112, half time of reduction of concentration of the
injected HC03; () JHCO3, net HC03 reabsorption. *p < 0.01
compared with control. #P < 0.01 compared with AVP.
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seconds (17/6) and JHCO3 was 0.804 0.065 nmol cm2 s.
However, in the group where AVP plus Anti-V2 was adminis-
tered, the parameters of acidification were similar to the AVP
group values: in the ED segment the t,2 was 4.89 0.25 1 second
(27/6) and JHCO3 was 1.66 0.101 nmol cm 2 and in the
LD segment the t112 was 4.40 0,231 second (19/5) and JHCO3
was 1.70 0.151 nmol cm2 s'.
It is known that in ED segments, HCO3 reabsorption is
mediated mostly by Na-H exchange [15, 181, and in LD
segments by Na -H exchange [151 and vacuolar H-ATPase [15,
18]. In the next series of experiments, we determined the specific
mechanisms by which luminal AVP was stimulating HCO3
reabsorption.
Effect of HMA 10" M
Figure 4 summarizes the results obtained in ED (Fig. 4A) and
LD (Fig. 4B) segments during luminal perfusion with AVP plus
HMA, a specific blocker of Na-H exchange. In ED segments,
HMA inhibited the stimulation of HCO3 reabsorption induced
by AVP: the t112 increased to 11.3 0.832 s (22/7) (P < 0.01 as
compared to AVP), and JHCO3 decreased to 0.771 0.071
nmol cm2 s' (P < 0.01). In LD segments, HMA also inhibited
the stimulation induced by AVP. The t112 increased to 6.55
0.511 s (17/6) (P < 0.01 as compared to AVP) and JHCO3
decreased to 1.10 0.122 nmol em 2 . S (P < 0.01). These
data show that in ED and LD tubules AVP stimulates the
Na-H exchanger responsible for HC03 reabsorption.
Effect of bafilomycin A1 2 x iO M
Data obtained during luminal perfusion with AVP plus bafilo-
mycin A1, a highly specific inhibitor of vacuolar H -ATPase, are
given in Figure 4 for the ED and LD segments. Bafilomycin A1 did
not inhibit the stimulation of ED HC01 reabsorption induced by
AVP. The t1,2 was 5.59 0.331 s (18/5), and JHCO1 was 1.68
0.091 nmol cm2 s1. However, in LD segments, the t1,2 value
was significantly increased to 6.94 0.422 s (22/7) (P < 0.01
against AVP), resulting in a marked reduction in JHCO3 to
1.14 0.082 nmol cm2• s (P < 0.01). These results indicate
that AVP stimulates H1 -ATPase in LD segments.
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DISCUSSION
In the present study, we have investigated the effect of arginine
vasopressin (AVP) on the kinetics of HCO reabsorption in both
early distal (ED) and late distal (LD) segments. We examined the
effect of luminal perfusion of the hormone in vivo by a stopped-
flow microperfusion technique, which is not affected by the
glomerular filtration rate. This procedure also avoids systemic
alterations caused by hormone infusion, confirmed by absence of
changes in urine flow, Na excretion, and systemic acid-base
values during experiments where luminal perfusion was per-
formed. Furthermore, the perfusion solutions contain raffinose to
reach isotonicity, a non-reabsorbable molecule, in order to pre-
vent the water flow induced by the hormone. Another advantage
of the luminal perfusion is to ascertain that the measurements of
acidification kinetics are performed at well-determined hormonal
levels, as it is known that some peptides have a short half-life
when injected parenterally. This is important since AVP is
partially catabolized in distal nephron segments [19], and an intact
structure of AVP is required for binding to the receptor [201.
In all experimental groups no significant differences from the
control group were observed in the intratubular steady-state pH
values in both ED and LD segments. Changes in this parameter
are related to several factors, including the rates of H secretion
and HC03 reabsorption. These findings suggest that the main
driving force for H secretion across the apical membrane is not
altered during our experiments.
Effect of AVP in early and late distal tubules
Our results indicate that AVP has a direct effect stimulating
HC03 reabsorption in ED and LD segments, expressed by a
significant fall in acidification half-time and consequent increase
in JHCO3 (Fig. 1). This effect was observed when the hormone
was perfused luminally, which we show here for the first time.
However, the present demonstration of AVP-induced enhance-
ment of HC01 reabsorption by distal tubules is not the first in
vivo study of this kind. During hypotonic volume expansion in the
rat, Bichara et al [2] examined the acute effects of systemic
DDAVP (1-desamino-8-D-arginine vasopressin), showing that net
total CO2 secretion was reversed to net HC03 reabsorption. On
the other hand, our results complement the in vitro rat CCD
studies of Tomita et a! [5] and the findings of Levine et al on distal
tubules of normally fed rats [4], which showed AVP-stimulated
HCO3 reabsorption. However, since in these studies the nature
of mechanisms underlying AVP stimulation was not defined, we
decided to determine and then study which specific process AVP
stimulates distal UC03 reabsorption.
Effect of AVP plus Anti-Vi or Anti-V2
We chose the Vi-receptor specific antagonist (Anti-VI, [d
(CH2)5, Tyr (Et)2] arginine vasopressin) to use as blocker of
Vi-receptors [21, 221, and as blocker of V2-receptors the V2-
receptor specific antagonist (Anti-V2, [Adamantaneacetyl1, 0-Et-
D-Tyr2, Va!4, Aminobutyryl6, Arg8'9 vasopressin) [23, 24]. We
believe that the effect of AVP during luminal perfusion occurs via
activation of VI receptors at the luminal membrane, since the
stimulatory effect in response to luminal AVP in ED and LD
segments was prevented by simultaneous luminal perfusion with
VI-antagonist (Fig. 3). These data are in accordance with the
identification of V 1-receptors for AVP in distal nephron, espe-
cially in the cortical portion of the collecting duct [25].
It has generally been accepted that the receptors for AVP are
located in the basolateral membranes of renal tubular epithelia.
However, by an electrophysiological study Naruse et al [261
reported for the first time that AVP acts not only on the
basolateral membrane, but also on the apical membrane of the
cortical collecting duct. In confirmation of this initial observation,
the authors obtained evidence that V1 receptors mediated luminal
action of AVP in cortical ascending limb, distal convoluted tubule,
connecting tubule and cortical collecting duct [27]. In addition,
luminal AVP has effects on intracellular calcium in medullary
ascending limb [28] and cortical collecting duct [29]. Taken
together, these data with the present results suggest that luminal
AVP might have a significant role in the regulation of HC01
reabsorption of the ED and LD segments, via V1 receptors.
Effect of AVP plus HMA
We chose to use HMA as a specific blocker of the Na
exchanger, with an inhibition constant of > 400 /tM for Na
channels and 0.16 jtM for the Na-H exchanger [30]. In a
previous study Fernandez et a! [15], by in vivo microperfusion in
rats, found that net JHCO3 is decreased in both ED [from
0.68 0.13 (N = 8/8) to 0.33 0.07 (N = 16/8) nmol cm2 s]
and LD segments [from 0.75 0.09 (N = 10/6) to 0.35 0.08
(N = 11/6) nmol cm2 s 'j during luminal perfusion with HMA
(10 M). Thus, their data showed that mostly ED, but also partly
LD segments, possess a mechanism of Na-H exchange respon-
sible for JHCO3. The present results obtained in ED segments
suggest that AVP stimulates the Na-H exchanger at the apical
membrane, since luminal perfusion with AVP plus HMA (at the
same dose used by Fernandez et a! [15], i0 M) reduced JHCO3
by a mean value of 63.7% compared with AVP alone (Fig. 4A).
However, the inhibitory effect of HMA in LD segments (34.1%)
was smaller than its effect in ED segments (Fig. 4B). This result is
in accordance with the data indicating that in ED segments
HCO3 reabsorption is mediated predominantly by Na-H
exchange [15, 18]. The significant but smaller effect of HMA on
LD action of AVP supports the existence of a minority participa-
tion of Na/H exchange in this segment [15]. It is interesting that
no significant effect of HMA on intratubular steady-state pH was
found, but acidification t112 values were markedly increased. Work
from our laboratory has shown that the steady-state pH gradient
depends on the driving force for H secretion (in this case, the
Na gradient across apical membrane), which is apparently
unchanged by HMA [311. The observed increase in acidification
11/2 is compatible with reduction of the density of exchangers or of
their turnover at the apical membrane, so that it takes a longer
period of time to reach the same maximal gradient. This modifi-
cation appears to be caused by the inhibitor, which competes with
Na for the reaction site on the transporters, effectively reducing
the number of active transporters.
Our results showing that AVP stimulates Na-H exchangers
in distal segments and that this action is mediated by V1-reccptors
agree with the signal-transduction pathways that have been de-
fined by a number of workers. It has been demonstrated that the
effect mediated by stimulation of V7 receptors is sensitive at
basolateral AVP concentrations of about 10 -12 to io' M [26, 27]
and results in an increase in intracellular cAMP concentration. By
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contrast, a higher concentration of AVP (10— 10 to iO° M), such
as the concentration used in the present work, is required to cause
a measurable increase in cytoplasmic Ca24 concentration in the
collecting ducts by stimulation of V1 receptors [32]. On the other
hand, luminal AVP acts on intracellular Ca24 in CCD principal
cells [29] and medullary thick ascending limb [28]. Based on these
observations and ott our findings, we believe that the effects of
luminal AVP (10-v M) observed in our study are mediated by V1
receptors in luminal membrane, rather than by V2 receptors,
which are sensitive to much lower AVP levels and, by liberating
cAMP, are expected to inhibit Na-H4 exchange. On the other
hand, it has been shown that stimulation of V1 receptors increases
cytoplasmic Ca24 concentration [32] and a rise in intracellular
Ca24 stimulates Na4-H4 exchange in many cells and increases
HC03 reabsorption in proximal convoluted tubule [33]. Further-
more, V2-receptors have not yet been identified in apical mem-
brane [34], and recently Yoshitomi et al [35] demonstrated that
AVP stimulates luminal Na4 conductance mediated by Vi-
receptor in the rabbit CCD.
Effect of AVP plus bafilomycin A1
Bafilomycin Al has been shown to be a highly specific inhibitor
of the vacuolar type of H4-ATPase [36]. In ED segments of rat, by
means of in vivo microperfusion experiments, no significant effect
of luminal bafilomycin A1 (2 x iO M) on net JHCO3 was
observed; in LD loops, however, JHCO1 values were signifi-
cantly decreased [from 1.18 0.120 (N = 19/11) to 0.60 0.054(N = 35/9) nmol cm2 s 1j [15]. Thus, these results indicate
that in LD tubule an H4-ATPase of the vacuolar type also
contributes to tubular acidification. Our results suggest that in ED
segments, bafilomycin A1 (2 >< i0— M) did not impair the
stimulation induced by AVP (Fig. 4A). However, our data indi-
cate that AVP stimulates H-ATPase in LD segments, since
luminal perfusion with AVP plus bafilomycin reduced JHCO3 by
a mean value of 31.7% compared with AVP alone (Fig. 4B).
These findings are consistent with data showing that this ATPase
occurs predominantly in LD segments and that bafilomyciri A1 at
the used concentration had no significant effect on ED acidifica-
tion [15, 18]. The inhibition of electrogenic H4 secretion is
expected to increase the lumen-negative V1; however, Table 1
shows no significant alteration of V during perfusions with
bafilomycin, suggesting that the transfer of H4 possibly is being
electrically neutralized by the conductance of other co- or
counter-ions. The absence of a significant effect of bafilomycin on
V has been shown before [15], suggesting that H -ATPase does
not participate in V1 in a major way. Nevertheless, in contrast with
our results, Ando, Tabei and Asano [12] have shown that luminal
i0° M AVP hyperpolarized collecting duct transepithelial poten-
tial difference, an effect reverted by acetazolamide. They sug-
gested that AVP might impair electrogenic H' secretion in this
segment. The reason for these differences is not clear, however, it
should be remembered that the cited authors did not measured
H secretion directly.
The effect of AVP on electrogenic vacuolar H4-ATPase in LD
epithelium is compatible with the presence of intercalated cells in
both connecting segment and initial collecting duct. However, the
present study does not establish the cellular site of the AVP effect.
Stimulation of H4-ATPase activity in type A intercalated cells
would increase tubule fluid acidification, an effect compatible with
our present results. Because bicarbonate secretion by the type B
intercalated cells is associated with luminal alkalinization, it
appears unlikely that the stimulatory effect of AVP on
ATPase activity in the rat LD segments shown in the present work
should occur in this subpopulation of intercalated cells, particu-
larly since it is known that, in rats, the majority of intercalated
cells is of the A type [37].
The mechanism behind the effect of AVP on H4-ATPase
activity in LD segments is unknown. The role of an increase in cell
Ca2 has been mentioned above [32]. However, the precise nature
of the signaling pathways involved in mediating the effect of AVP
on H4-ATPase activity in LD segments remains to be established.
We have not investigated the possible effect of AVP on
H4-K4-ATPase, since it was shown that this transporter is
expressed only in potassium depletion in this segment [15, 18].
On the other hand, the possible physiological role of luminal
AVP action should also be considered. The concentration of AVP
in the luminal fluid may exceed that of plasma, even under
physiological conditions. Data from kinetic studies and from renal
clearances suggested that the tubular secretion of vasopressin into
the distal ncphron is an important component of the renal
clearance of this hormone in humans [38], dogs [39, 40] and rats
[41]. In humans, AVP clearance is in the range of 0.1 to 2
mi/kg/mm, and urine AVP levels range from 5 to 500 ps [29].
Ando, Tabei and Asano [12] reported that water permeability
stimulated by basolateral AVP was inhibited by luminal AVP
within this concentration range. Luminal AVP at the concentra-
tion of 100 p increased intracellular Ca24 [29] and changed ionic
conductances of the microperfused rabbit CCD [26, 27]. These
data taken together with the present results suggest that luminal
AVP might have a significant role in the regulation of tubule
transport of water and ions, especially when AVP concentration is
high.
In conclusion, we performed in vivo stationary microperfusion
studies in the cortical ED and LD tubules of the rat to evaluate
the effects of luminal AVP (10° NI) on HCO reabsorption. Our
results indicate for the first time that luminal AVP significantly
stimulates HC03 reabsorption in in vivo ED and LD segments
via activation of VI receptors. Luminal AVP acts stimulating
Na' -H4 exchange mainly in ED segments. Evidence has also
been obtained for stimulation of the vacuolar H4-ATPase in LD
segments. The present work, however, does not allow us to ascribe
the results with AVP to any specific cell type that might contribute
to acidification in cortical distal tubule.
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